Aussies help pioneer non-invasive bladder cancer test

Melbourne-based Sienna Cancer Diagnostics’ lead product is the anti-hTERT SCD-A7 antibody that can be used in diagnostic tests to detect telomerase, an enzyme associated with around 90 % of human cancers.

A US pathology firm will use the SCD-A7 antibody in the world’s first stain test to detect telomerase for bladder cancer.

# Tags